期刊文献+

人vWF A3-Flag-GPI融合蛋白的设计和生物活性预测

Design of human vWF A3-Flag-GPI fusion protein and its biologic characteristics prediction
下载PDF
导出
摘要 目的探讨hvWF A3-Flag-GPI融合蛋白设计的合理性,以期获得能够锚定至内皮祖细胞表面,引导细胞黏附于受损血管壁的分子。方法应用Gene Construction Kit2.5,www.expasy.com网站提供的分析方案,分析重组体的开放读框及融合蛋白的柔性,并作了蛋白质二级结构模拟。结果重组体Flag linker所在部位柔性高,融合蛋白表达后,二级结构预测Flag lin-ker不改变蛋白结构,完全符合作者设计hvWF A3-Flag-GPI融合蛋白的初衷。结论重组蛋白设计合理,融合蛋白有很大可能保留了hvWF A3和GPI的理化特性,为获得引导EPCs特异归巢至受损血管壁的相关分子提供前期基础。 Objective To study the reasonability of designation of hvWF A3-Flag-GPI fusion protein. Methods Using sequence analysis software and protocols prescribed on website www. expasy, corn to analyze the open reading frame of the recombinant and the flexibility.as well as the secondary structure of hvWF A3-Flag-GPI fusion protein. Results The fusion protein had correct domains of hvWF A3-Flag-GPI. Flag linker had high flexibility and did not influence the secondary structure of fusion protein. Conclusion Computer analysis can help to rationally design the recombinant protein. The attenuated hvWF A3 and GPI protein keep their maximum biological activities.
出处 《重庆医学》 CAS CSCD 2008年第9期924-925,共2页 Chongqing medicine
基金 国家自然科学基金资助项目(30470729)。
关键词 血管性假血友病因子 糖基化磷脂酰肌醇 分子结构预测 vWF GPI Molecular structure prediction
  • 相关文献

参考文献9

二级参考文献44

  • 1全硕,鲁重美,方福德,潘国宗.人甲胎蛋白基因顺式作用元件的重新组合[J].基础医学与临床,1996,16(1):31-38. 被引量:4
  • 2张威,周莉,金惠铭,曲晓义,张国平,殷莲华,朱大年.用CD133免疫磁珠分离脐血内皮祖细胞的实验研究[J].中国病理生理杂志,2005,21(9):1675-1680. 被引量:7
  • 3崔斌,黄岚,耿召华,方玉强,宋明宝,赵晓辉.人循环内皮祖细胞的分离培养和诱导分化[J].重庆医学,2006,35(5):420-422. 被引量:8
  • 4夏菁,陈光辉,刘宏斌.干细胞移植治疗在心血管疾病中应用的研究进展[J].中华老年心脑血管病杂志,2006,8(3):210-211. 被引量:2
  • 5金冬雁 黎孟枫(等).分子克隆实验指南(第二版)[M].北京:科学出版社,1992.60-69.
  • 6Wu D, Vanhoorelbeke K, Cauwenberghs N, et al. Inhibition of the von Willebrand factor(vWF) -collagen interaction by an antihuman vWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons. Blood,2002;99:3623-36
  • 7Cruz MA, Yuan H, Lee JR, et al. Interaction of the von Willebrand factor(vWF) with collagen. Localization of the primary collagenbinding site by analysis of recombinant vWF a domain polypeptides. J Biol Chem,1995;270:10822-10827
  • 8Emsley J, Cruz M, Handin R, et al. Crystal structure of the von Willebrand factor A1 domain and implications for the binding of platelet glycoprotein Ib. J Biol Chem,1998;273:10396-10401
  • 9Ulrichts H, Depraetere H, Harsfalvi J, et al. Selection of phages that inhibit vWF interaction with collagen under both static and flow conditions. Thromb Haemost,2001;86:630-635
  • 10Wagner DD. Cell biology of von Willebrand factor. Ann Rev Cell Biol,1990;6:217-246

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部